Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.

Publication ,  Journal Article
Hong, CC; Tang, AT; Detter, MR; Choi, JP; Wang, R; Yang, X; Guerrero, AA; Wittig, CF; Hobson, N; Girard, R; Lightle, R; Moore, T; Shenkar, R ...
Published in: J Exp Med
October 5, 2020

Cerebral cavernous malformations (CCMs) form following loss of the CCM protein complex in brain endothelial cells due to increased endothelial MEKK3 signaling and KLF2/4 transcription factor expression, but the downstream events that drive lesion formation remain undefined. Recent studies have revealed that CCM lesions expand by incorporating neighboring wild-type endothelial cells, indicative of a cell nonautonomous mechanism. Here we find that endothelial loss of ADAMTS5 reduced CCM formation in the neonatal mouse model. Conversely, endothelial gain of ADAMTS5 conferred early lesion genesis in the absence of increased KLF2/4 expression and synergized with KRIT1 loss of function to create large malformations. Lowering versican expression reduced CCM burden, indicating that versican is the relevant ADAMTS5 substrate and that lesion formation requires proteolysis but not loss of this extracellular matrix protein. These findings identify endothelial secretion of ADAMTS5 and cleavage of versican as downstream mechanisms of CCM pathogenesis and provide a basis for the participation of wild-type endothelial cells in lesion formation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Exp Med

DOI

EISSN

1540-9538

Publication Date

October 5, 2020

Volume

217

Issue

10

Location

United States

Related Subject Headings

  • White Matter
  • Versicans
  • Proteolysis
  • Mice, Inbred DBA
  • Mice, Inbred C57BL
  • Mice
  • Male
  • Immunology
  • Hemangioma, Cavernous, Central Nervous System
  • Genetic Association Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hong, C. C., Tang, A. T., Detter, M. R., Choi, J. P., Wang, R., Yang, X., … Kahn, M. L. (2020). Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J Exp Med, 217(10). https://doi.org/10.1084/jem.20200140
Hong, Courtney C., Alan T. Tang, Matthew R. Detter, Jaesung P. Choi, Rui Wang, Xi Yang, Andrea A. Guerrero, et al. “Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.J Exp Med 217, no. 10 (October 5, 2020). https://doi.org/10.1084/jem.20200140.
Hong CC, Tang AT, Detter MR, Choi JP, Wang R, Yang X, et al. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J Exp Med. 2020 Oct 5;217(10).
Hong, Courtney C., et al. “Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.J Exp Med, vol. 217, no. 10, Oct. 2020. Pubmed, doi:10.1084/jem.20200140.
Hong CC, Tang AT, Detter MR, Choi JP, Wang R, Yang X, Guerrero AA, Wittig CF, Hobson N, Girard R, Lightle R, Moore T, Shenkar R, Polster SP, Goddard LM, Ren AA, Leu NA, Sterling S, Yang J, Li L, Chen M, Mericko-Ishizuka P, Dow LE, Watanabe H, Schwaninger M, Min W, Marchuk DA, Zheng X, Awad IA, Kahn ML. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J Exp Med. 2020 Oct 5;217(10).

Published In

J Exp Med

DOI

EISSN

1540-9538

Publication Date

October 5, 2020

Volume

217

Issue

10

Location

United States

Related Subject Headings

  • White Matter
  • Versicans
  • Proteolysis
  • Mice, Inbred DBA
  • Mice, Inbred C57BL
  • Mice
  • Male
  • Immunology
  • Hemangioma, Cavernous, Central Nervous System
  • Genetic Association Studies